Published in

BioMed Central, Cardiovascular Diabetology, 1(13), 2014

DOI: 10.1186/1475-2840-13-64

Links

Tools

Export citation

Search in Google Scholar

Gender disparity in LDL-induced cardiovascular damage and the protective role of estrogens against electronegative LDL

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Background: Increased levels of the most electronegative type of LDL, L5, have been observed in the plasma of patients with metabolic syndrome (MetS) and ST-segment elevation myocardial infarction and can induce endothelial dysfunction. Because men have a higher predisposition to developing coronary artery disease than do premenopausal women, we hypothesized that LDL electronegativity is increased in men and promotes endothelial damage. Methods: L5 levels were compared between middle-aged men and age-matched, premenopausal women with or without MetS. We further studied the effects of gender-influenced LDL electronegativity on aortic cellular senescence and DNA damage in leptin receptor-deficient (db/db) mice by using senescence-associated-beta-galactosidase and gamma H2AX staining, respectively. We also studied the protective effects of 17 beta-estradiol and genistein against electronegative LDL-induced senescence in cultured bovine aortic endothelial cells (BAECs). Results: L5 levels were higher in MetS patients than in healthy subjects (P